nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—AOX1—prostate cancer	0.285	0.753	CbGaD
Zonisamide—AOX1—Ethinyl Estradiol—prostate cancer	0.0809	0.29	CbGbCtD
Zonisamide—CYP2C19—prostate cancer	0.0572	0.151	CbGaD
Zonisamide—AOX1—Estradiol—prostate cancer	0.0522	0.187	CbGbCtD
Zonisamide—CYP3A4—prostate cancer	0.0364	0.0961	CbGaD
Zonisamide—CYP2C19—Nilutamide—prostate cancer	0.0185	0.0662	CbGbCtD
Zonisamide—CYP2C19—Bicalutamide—prostate cancer	0.0185	0.0662	CbGbCtD
Zonisamide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.017	0.0609	CbGbCtD
Zonisamide—CYP2C19—Flutamide—prostate cancer	0.0153	0.0548	CbGbCtD
Zonisamide—CYP3A4—Bicalutamide—prostate cancer	0.00894	0.032	CbGbCtD
Zonisamide—CYP3A4—Estramustine—prostate cancer	0.00831	0.0297	CbGbCtD
Zonisamide—CYP3A4—Abiraterone—prostate cancer	0.00741	0.0265	CbGbCtD
Zonisamide—CYP3A4—Flutamide—prostate cancer	0.00741	0.0265	CbGbCtD
Zonisamide—CYP2C19—Estradiol—prostate cancer	0.00636	0.0228	CbGbCtD
Zonisamide—CYP3A4—Cabazitaxel—prostate cancer	0.00548	0.0196	CbGbCtD
Zonisamide—CYP2C19—Prednisone—prostate cancer	0.00547	0.0196	CbGbCtD
Zonisamide—CYP3A4—Estrone—prostate cancer	0.00536	0.0192	CbGbCtD
Zonisamide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00477	0.0171	CbGbCtD
Zonisamide—CYP3A4—Conjugated Estrogens—prostate cancer	0.0035	0.0125	CbGbCtD
Zonisamide—CYP3A4—Mitoxantrone—prostate cancer	0.00319	0.0114	CbGbCtD
Zonisamide—CYP3A4—Estradiol—prostate cancer	0.00308	0.011	CbGbCtD
Zonisamide—SCN1B—prostate gland—prostate cancer	0.00278	0.0426	CbGeAlD
Zonisamide—CYP3A4—Prednisone—prostate cancer	0.00265	0.00946	CbGbCtD
Zonisamide—CA8—prostate gland—prostate cancer	0.00261	0.04	CbGeAlD
Zonisamide—SCN3B—prostate gland—prostate cancer	0.00256	0.0393	CbGeAlD
Zonisamide—CA13—prostate gland—prostate cancer	0.00223	0.0343	CbGeAlD
Zonisamide—SCN4B—prostate gland—prostate cancer	0.00218	0.0334	CbGeAlD
Zonisamide—CYP3A4—Etoposide—prostate cancer	0.00201	0.00719	CbGbCtD
Zonisamide—CA11—prostate gland—prostate cancer	0.00187	0.0288	CbGeAlD
Zonisamide—SCN4B—seminal vesicle—prostate cancer	0.00184	0.0283	CbGeAlD
Zonisamide—CYP3A4—Docetaxel—prostate cancer	0.00184	0.00657	CbGbCtD
Zonisamide—CA11—seminal vesicle—prostate cancer	0.00159	0.0243	CbGeAlD
Zonisamide—SCN4B—urethra—prostate cancer	0.00146	0.0224	CbGeAlD
Zonisamide—CYP3A4—Doxorubicin—prostate cancer	0.00137	0.0049	CbGbCtD
Zonisamide—CYP2C19—urine—prostate cancer	0.00126	0.0194	CbGeAlD
Zonisamide—CA11—urethra—prostate cancer	0.00126	0.0193	CbGeAlD
Zonisamide—SCN1B—testis—prostate cancer	0.00122	0.0188	CbGeAlD
Zonisamide—CA10—testis—prostate cancer	0.00117	0.018	CbGeAlD
Zonisamide—CA8—testis—prostate cancer	0.00115	0.0176	CbGeAlD
Zonisamide—CA3—prostate gland—prostate cancer	0.00114	0.0176	CbGeAlD
Zonisamide—SCN3B—testis—prostate cancer	0.00113	0.0173	CbGeAlD
Zonisamide—CA14—prostate gland—prostate cancer	0.00104	0.0159	CbGeAlD
Zonisamide—SCN9A—prostate gland—prostate cancer	0.00102	0.0156	CbGeAlD
Zonisamide—CA13—testis—prostate cancer	0.000984	0.0151	CbGeAlD
Zonisamide—CA11—bone marrow—prostate cancer	0.000966	0.0148	CbGeAlD
Zonisamide—SCN4B—testis—prostate cancer	0.00096	0.0147	CbGeAlD
Zonisamide—CACNA1H—prostate gland—prostate cancer	0.000954	0.0146	CbGeAlD
Zonisamide—CACNA1I—testis—prostate cancer	0.000937	0.0144	CbGeAlD
Zonisamide—SCN4A—prostate gland—prostate cancer	0.000908	0.0139	CbGeAlD
Zonisamide—SCN1B—lymph node—prostate cancer	0.000886	0.0136	CbGeAlD
Zonisamide—CA14—seminal vesicle—prostate cancer	0.000879	0.0135	CbGeAlD
Zonisamide—CA7—renal system—prostate cancer	0.00085	0.013	CbGeAlD
Zonisamide—CA8—lymph node—prostate cancer	0.000833	0.0128	CbGeAlD
Zonisamide—CA11—testis—prostate cancer	0.000826	0.0127	CbGeAlD
Zonisamide—SCN3B—lymph node—prostate cancer	0.000818	0.0125	CbGeAlD
Zonisamide—CACNA1H—seminal vesicle—prostate cancer	0.000807	0.0124	CbGeAlD
Zonisamide—CYP3A4—urine—prostate cancer	0.000748	0.0115	CbGeAlD
Zonisamide—CA5B—prostate gland—prostate cancer	0.000727	0.0112	CbGeAlD
Zonisamide—CA13—lymph node—prostate cancer	0.000713	0.0109	CbGeAlD
Zonisamide—SCN3A—prostate gland—prostate cancer	0.000706	0.0108	CbGeAlD
Zonisamide—SCN4B—lymph node—prostate cancer	0.000696	0.0107	CbGeAlD
Zonisamide—CACNA1I—lymph node—prostate cancer	0.000679	0.0104	CbGeAlD
Zonisamide—AOX1—prostate gland—prostate cancer	0.000676	0.0104	CbGeAlD
Zonisamide—SCN4A—renal system—prostate cancer	0.000619	0.0095	CbGeAlD
Zonisamide—CA11—lymph node—prostate cancer	0.000599	0.00919	CbGeAlD
Zonisamide—CA3—bone marrow—prostate cancer	0.00059	0.00905	CbGeAlD
Zonisamide—AOX1—seminal vesicle—prostate cancer	0.000572	0.00877	CbGeAlD
Zonisamide—CA12—renal system—prostate cancer	0.000552	0.00847	CbGeAlD
Zonisamide—MAOB—prostate gland—prostate cancer	0.000521	0.00799	CbGeAlD
Zonisamide—CA3—testis—prostate cancer	0.000504	0.00773	CbGeAlD
Zonisamide—CA4—prostate gland—prostate cancer	0.000502	0.0077	CbGeAlD
Zonisamide—CA5B—urethra—prostate cancer	0.000487	0.00747	CbGeAlD
Zonisamide—CA9—testis—prostate cancer	0.000483	0.0074	CbGeAlD
Zonisamide—SCN3A—renal system—prostate cancer	0.000481	0.00739	CbGeAlD
Zonisamide—AOX1—renal system—prostate cancer	0.000461	0.00707	CbGeAlD
Zonisamide—AOX1—urethra—prostate cancer	0.000453	0.00694	CbGeAlD
Zonisamide—SCN9A—testis—prostate cancer	0.000448	0.00688	CbGeAlD
Zonisamide—MAOA—prostate gland—prostate cancer	0.000444	0.00682	CbGeAlD
Zonisamide—MAOB—seminal vesicle—prostate cancer	0.000441	0.00676	CbGeAlD
Zonisamide—CA1—renal system—prostate cancer	0.000437	0.00671	CbGeAlD
Zonisamide—CA4—seminal vesicle—prostate cancer	0.000424	0.00651	CbGeAlD
Zonisamide—CACNA1H—testis—prostate cancer	0.00042	0.00645	CbGeAlD
Zonisamide—CA2—prostate gland—prostate cancer	0.000416	0.00638	CbGeAlD
Zonisamide—SCN4A—testis—prostate cancer	0.0004	0.00614	CbGeAlD
Zonisamide—MAOA—seminal vesicle—prostate cancer	0.000376	0.00577	CbGeAlD
Zonisamide—CA3—lymph node—prostate cancer	0.000365	0.00561	CbGeAlD
Zonisamide—SCN3A—bone marrow—prostate cancer	0.000364	0.00558	CbGeAlD
Zonisamide—MAOB—renal system—prostate cancer	0.000355	0.00545	CbGeAlD
Zonisamide—CA2—seminal vesicle—prostate cancer	0.000352	0.0054	CbGeAlD
Zonisamide—MAOB—urethra—prostate cancer	0.000349	0.00535	CbGeAlD
Zonisamide—CA4—renal system—prostate cancer	0.000342	0.00525	CbGeAlD
Zonisamide—CA4—urethra—prostate cancer	0.000336	0.00515	CbGeAlD
Zonisamide—CA1—bone marrow—prostate cancer	0.000331	0.00507	CbGeAlD
Zonisamide—SCN9A—lymph node—prostate cancer	0.000325	0.00499	CbGeAlD
Zonisamide—CA5B—testis—prostate cancer	0.00032	0.00491	CbGeAlD
Zonisamide—SCN3A—testis—prostate cancer	0.000311	0.00477	CbGeAlD
Zonisamide—CA2—epithelium—prostate cancer	0.000306	0.00469	CbGeAlD
Zonisamide—CACNA1H—lymph node—prostate cancer	0.000305	0.00467	CbGeAlD
Zonisamide—MAOA—renal system—prostate cancer	0.000303	0.00465	CbGeAlD
Zonisamide—AOX1—testis—prostate cancer	0.000298	0.00457	CbGeAlD
Zonisamide—MAOA—urethra—prostate cancer	0.000298	0.00456	CbGeAlD
Zonisamide—CA2—renal system—prostate cancer	0.000284	0.00435	CbGeAlD
Zonisamide—CA4—bone marrow—prostate cancer	0.000259	0.00397	CbGeAlD
Zonisamide—CA5B—lymph node—prostate cancer	0.000232	0.00356	CbGeAlD
Zonisamide—MAOB—testis—prostate cancer	0.000229	0.00352	CbGeAlD
Zonisamide—SCN3A—lymph node—prostate cancer	0.000226	0.00346	CbGeAlD
Zonisamide—CA4—testis—prostate cancer	0.000221	0.00339	CbGeAlD
Zonisamide—AOX1—lymph node—prostate cancer	0.000216	0.00331	CbGeAlD
Zonisamide—CA2—bone marrow—prostate cancer	0.000214	0.00329	CbGeAlD
Zonisamide—CA1—lymph node—prostate cancer	0.000205	0.00314	CbGeAlD
Zonisamide—MAOA—testis—prostate cancer	0.000196	0.003	CbGeAlD
Zonisamide—CA2—testis—prostate cancer	0.000183	0.00281	CbGeAlD
Zonisamide—CYP3A4—renal system—prostate cancer	0.000183	0.00281	CbGeAlD
Zonisamide—MAOB—lymph node—prostate cancer	0.000166	0.00255	CbGeAlD
Zonisamide—CA4—lymph node—prostate cancer	0.00016	0.00246	CbGeAlD
Zonisamide—MAOA—lymph node—prostate cancer	0.000142	0.00218	CbGeAlD
Zonisamide—CA2—lymph node—prostate cancer	0.000133	0.00204	CbGeAlD
Zonisamide—Urethral disorder—Epirubicin—prostate cancer	2.93e-05	0.000181	CcSEcCtD
Zonisamide—Loss of consciousness—Prednisone—prostate cancer	2.93e-05	0.00018	CcSEcCtD
Zonisamide—Hepatobiliary disease—Doxorubicin—prostate cancer	2.91e-05	0.00018	CcSEcCtD
Zonisamide—Anorexia—Capecitabine—prostate cancer	2.91e-05	0.000179	CcSEcCtD
Zonisamide—Nausea—Estradiol—prostate cancer	2.9e-05	0.000179	CcSEcCtD
Zonisamide—Vomiting—Mitoxantrone—prostate cancer	2.9e-05	0.000178	CcSEcCtD
Zonisamide—Convulsion—Prednisone—prostate cancer	2.88e-05	0.000178	CcSEcCtD
Zonisamide—Agranulocytosis—Doxorubicin—prostate cancer	2.88e-05	0.000177	CcSEcCtD
Zonisamide—Hypertension—Prednisone—prostate cancer	2.87e-05	0.000177	CcSEcCtD
Zonisamide—Rash—Mitoxantrone—prostate cancer	2.87e-05	0.000177	CcSEcCtD
Zonisamide—Dermatitis—Mitoxantrone—prostate cancer	2.87e-05	0.000177	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.87e-05	0.000177	CcSEcCtD
Zonisamide—Headache—Mitoxantrone—prostate cancer	2.85e-05	0.000176	CcSEcCtD
Zonisamide—Hypotension—Capecitabine—prostate cancer	2.85e-05	0.000176	CcSEcCtD
Zonisamide—Insomnia—Docetaxel—prostate cancer	2.85e-05	0.000176	CcSEcCtD
Zonisamide—Arthralgia—Prednisone—prostate cancer	2.83e-05	0.000175	CcSEcCtD
Zonisamide—Myalgia—Prednisone—prostate cancer	2.83e-05	0.000175	CcSEcCtD
Zonisamide—Paraesthesia—Docetaxel—prostate cancer	2.83e-05	0.000174	CcSEcCtD
Zonisamide—Erythema multiforme—Epirubicin—prostate cancer	2.83e-05	0.000174	CcSEcCtD
Zonisamide—Anxiety—Prednisone—prostate cancer	2.82e-05	0.000174	CcSEcCtD
Zonisamide—Bradycardia—Doxorubicin—prostate cancer	2.82e-05	0.000174	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.81e-05	0.000173	CcSEcCtD
Zonisamide—Dyspnoea—Docetaxel—prostate cancer	2.81e-05	0.000173	CcSEcCtD
Zonisamide—Somnolence—Docetaxel—prostate cancer	2.8e-05	0.000173	CcSEcCtD
Zonisamide—Discomfort—Prednisone—prostate cancer	2.8e-05	0.000172	CcSEcCtD
Zonisamide—Eye disorder—Epirubicin—prostate cancer	2.79e-05	0.000172	CcSEcCtD
Zonisamide—Hypersensitivity—Etoposide—prostate cancer	2.79e-05	0.000172	CcSEcCtD
Zonisamide—Tinnitus—Epirubicin—prostate cancer	2.79e-05	0.000172	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.78e-05	0.000171	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—prostate cancer	2.77e-05	0.000171	CcSEcCtD
Zonisamide—Dyspepsia—Docetaxel—prostate cancer	2.77e-05	0.000171	CcSEcCtD
Zonisamide—Insomnia—Capecitabine—prostate cancer	2.76e-05	0.00017	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—prostate cancer	2.75e-05	0.000169	CcSEcCtD
Zonisamide—Paraesthesia—Capecitabine—prostate cancer	2.74e-05	0.000169	CcSEcCtD
Zonisamide—Decreased appetite—Docetaxel—prostate cancer	2.74e-05	0.000169	CcSEcCtD
Zonisamide—Urinary tract disorder—Doxorubicin—prostate cancer	2.73e-05	0.000168	CcSEcCtD
Zonisamide—Oedema peripheral—Doxorubicin—prostate cancer	2.73e-05	0.000168	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Docetaxel—prostate cancer	2.72e-05	0.000168	CcSEcCtD
Zonisamide—Asthenia—Etoposide—prostate cancer	2.72e-05	0.000168	CcSEcCtD
Zonisamide—Connective tissue disorder—Doxorubicin—prostate cancer	2.72e-05	0.000168	CcSEcCtD
Zonisamide—Dyspnoea—Capecitabine—prostate cancer	2.72e-05	0.000168	CcSEcCtD
Zonisamide—Oedema—Prednisone—prostate cancer	2.72e-05	0.000167	CcSEcCtD
Zonisamide—Fatigue—Docetaxel—prostate cancer	2.72e-05	0.000167	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—prostate cancer	2.71e-05	0.000167	CcSEcCtD
Zonisamide—Nausea—Mitoxantrone—prostate cancer	2.71e-05	0.000167	CcSEcCtD
Zonisamide—Immune system disorder—Epirubicin—prostate cancer	2.7e-05	0.000166	CcSEcCtD
Zonisamide—Infection—Prednisone—prostate cancer	2.7e-05	0.000166	CcSEcCtD
Zonisamide—Mediastinal disorder—Epirubicin—prostate cancer	2.69e-05	0.000166	CcSEcCtD
Zonisamide—Constipation—Docetaxel—prostate cancer	2.69e-05	0.000166	CcSEcCtD
Zonisamide—Dyspepsia—Capecitabine—prostate cancer	2.68e-05	0.000165	CcSEcCtD
Zonisamide—Pruritus—Etoposide—prostate cancer	2.68e-05	0.000165	CcSEcCtD
Zonisamide—Shock—Prednisone—prostate cancer	2.67e-05	0.000165	CcSEcCtD
Zonisamide—Nervous system disorder—Prednisone—prostate cancer	2.66e-05	0.000164	CcSEcCtD
Zonisamide—Tachycardia—Prednisone—prostate cancer	2.65e-05	0.000163	CcSEcCtD
Zonisamide—Decreased appetite—Capecitabine—prostate cancer	2.65e-05	0.000163	CcSEcCtD
Zonisamide—Alopecia—Epirubicin—prostate cancer	2.64e-05	0.000163	CcSEcCtD
Zonisamide—Skin disorder—Prednisone—prostate cancer	2.64e-05	0.000163	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Capecitabine—prostate cancer	2.63e-05	0.000162	CcSEcCtD
Zonisamide—Fatigue—Capecitabine—prostate cancer	2.63e-05	0.000162	CcSEcCtD
Zonisamide—Hyperhidrosis—Prednisone—prostate cancer	2.63e-05	0.000162	CcSEcCtD
Zonisamide—Mental disorder—Epirubicin—prostate cancer	2.62e-05	0.000161	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—prostate cancer	2.62e-05	0.000161	CcSEcCtD
Zonisamide—Constipation—Capecitabine—prostate cancer	2.61e-05	0.000161	CcSEcCtD
Zonisamide—Malnutrition—Epirubicin—prostate cancer	2.6e-05	0.00016	CcSEcCtD
Zonisamide—Feeling abnormal—Docetaxel—prostate cancer	2.6e-05	0.00016	CcSEcCtD
Zonisamide—Diarrhoea—Etoposide—prostate cancer	2.59e-05	0.00016	CcSEcCtD
Zonisamide—Anorexia—Prednisone—prostate cancer	2.59e-05	0.00016	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—prostate cancer	2.59e-05	0.000159	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—prostate cancer	2.58e-05	0.000159	CcSEcCtD
Zonisamide—Gastrointestinal pain—Docetaxel—prostate cancer	2.58e-05	0.000159	CcSEcCtD
Zonisamide—Flatulence—Epirubicin—prostate cancer	2.56e-05	0.000158	CcSEcCtD
Zonisamide—Tension—Epirubicin—prostate cancer	2.55e-05	0.000157	CcSEcCtD
Zonisamide—Dysgeusia—Epirubicin—prostate cancer	2.55e-05	0.000157	CcSEcCtD
Zonisamide—Nervousness—Epirubicin—prostate cancer	2.53e-05	0.000156	CcSEcCtD
Zonisamide—Feeling abnormal—Capecitabine—prostate cancer	2.51e-05	0.000155	CcSEcCtD
Zonisamide—Dizziness—Etoposide—prostate cancer	2.51e-05	0.000154	CcSEcCtD
Zonisamide—Muscle spasms—Epirubicin—prostate cancer	2.5e-05	0.000154	CcSEcCtD
Zonisamide—Immune system disorder—Doxorubicin—prostate cancer	2.5e-05	0.000154	CcSEcCtD
Zonisamide—Gastrointestinal pain—Capecitabine—prostate cancer	2.49e-05	0.000154	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—prostate cancer	2.49e-05	0.000154	CcSEcCtD
Zonisamide—Abdominal pain—Docetaxel—prostate cancer	2.49e-05	0.000153	CcSEcCtD
Zonisamide—Body temperature increased—Docetaxel—prostate cancer	2.49e-05	0.000153	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Prednisone—prostate cancer	2.47e-05	0.000152	CcSEcCtD
Zonisamide—Insomnia—Prednisone—prostate cancer	2.46e-05	0.000151	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—prostate cancer	2.44e-05	0.000151	CcSEcCtD
Zonisamide—Paraesthesia—Prednisone—prostate cancer	2.44e-05	0.00015	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—prostate cancer	2.42e-05	0.000149	CcSEcCtD
Zonisamide—Urticaria—Capecitabine—prostate cancer	2.42e-05	0.000149	CcSEcCtD
Zonisamide—Ill-defined disorder—Epirubicin—prostate cancer	2.42e-05	0.000149	CcSEcCtD
Zonisamide—Abdominal pain—Capecitabine—prostate cancer	2.41e-05	0.000149	CcSEcCtD
Zonisamide—Body temperature increased—Capecitabine—prostate cancer	2.41e-05	0.000149	CcSEcCtD
Zonisamide—Vomiting—Etoposide—prostate cancer	2.41e-05	0.000148	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—prostate cancer	2.41e-05	0.000148	CcSEcCtD
Zonisamide—Anaemia—Epirubicin—prostate cancer	2.41e-05	0.000148	CcSEcCtD
Zonisamide—Agitation—Epirubicin—prostate cancer	2.39e-05	0.000147	CcSEcCtD
Zonisamide—Dyspepsia—Prednisone—prostate cancer	2.39e-05	0.000147	CcSEcCtD
Zonisamide—Rash—Etoposide—prostate cancer	2.39e-05	0.000147	CcSEcCtD
Zonisamide—Dermatitis—Etoposide—prostate cancer	2.39e-05	0.000147	CcSEcCtD
Zonisamide—Headache—Etoposide—prostate cancer	2.37e-05	0.000146	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—prostate cancer	2.37e-05	0.000146	CcSEcCtD
Zonisamide—Tension—Doxorubicin—prostate cancer	2.36e-05	0.000146	CcSEcCtD
Zonisamide—Decreased appetite—Prednisone—prostate cancer	2.36e-05	0.000145	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—prostate cancer	2.36e-05	0.000145	CcSEcCtD
Zonisamide—Malaise—Epirubicin—prostate cancer	2.35e-05	0.000145	CcSEcCtD
Zonisamide—Fatigue—Prednisone—prostate cancer	2.34e-05	0.000144	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—prostate cancer	2.34e-05	0.000144	CcSEcCtD
Zonisamide—Vertigo—Epirubicin—prostate cancer	2.34e-05	0.000144	CcSEcCtD
Zonisamide—Syncope—Epirubicin—prostate cancer	2.33e-05	0.000144	CcSEcCtD
Zonisamide—Leukopenia—Epirubicin—prostate cancer	2.33e-05	0.000144	CcSEcCtD
Zonisamide—Constipation—Prednisone—prostate cancer	2.32e-05	0.000143	CcSEcCtD
Zonisamide—Hypersensitivity—Docetaxel—prostate cancer	2.32e-05	0.000143	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—prostate cancer	2.32e-05	0.000143	CcSEcCtD
Zonisamide—Palpitations—Epirubicin—prostate cancer	2.3e-05	0.000142	CcSEcCtD
Zonisamide—Loss of consciousness—Epirubicin—prostate cancer	2.29e-05	0.000141	CcSEcCtD
Zonisamide—Cough—Epirubicin—prostate cancer	2.27e-05	0.00014	CcSEcCtD
Zonisamide—Asthenia—Docetaxel—prostate cancer	2.26e-05	0.000139	CcSEcCtD
Zonisamide—Convulsion—Epirubicin—prostate cancer	2.26e-05	0.000139	CcSEcCtD
Zonisamide—Nausea—Etoposide—prostate cancer	2.25e-05	0.000139	CcSEcCtD
Zonisamide—Hypertension—Epirubicin—prostate cancer	2.25e-05	0.000138	CcSEcCtD
Zonisamide—Hypersensitivity—Capecitabine—prostate cancer	2.25e-05	0.000138	CcSEcCtD
Zonisamide—Feeling abnormal—Prednisone—prostate cancer	2.24e-05	0.000138	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—prostate cancer	2.23e-05	0.000138	CcSEcCtD
Zonisamide—Pruritus—Docetaxel—prostate cancer	2.23e-05	0.000137	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—prostate cancer	2.23e-05	0.000137	CcSEcCtD
Zonisamide—Gastrointestinal pain—Prednisone—prostate cancer	2.22e-05	0.000137	CcSEcCtD
Zonisamide—Arthralgia—Epirubicin—prostate cancer	2.22e-05	0.000137	CcSEcCtD
Zonisamide—Chest pain—Epirubicin—prostate cancer	2.22e-05	0.000137	CcSEcCtD
Zonisamide—Myalgia—Epirubicin—prostate cancer	2.22e-05	0.000137	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—prostate cancer	2.21e-05	0.000136	CcSEcCtD
Zonisamide—Anxiety—Epirubicin—prostate cancer	2.21e-05	0.000136	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.2e-05	0.000136	CcSEcCtD
Zonisamide—Discomfort—Epirubicin—prostate cancer	2.19e-05	0.000135	CcSEcCtD
Zonisamide—Asthenia—Capecitabine—prostate cancer	2.19e-05	0.000135	CcSEcCtD
Zonisamide—Malaise—Doxorubicin—prostate cancer	2.17e-05	0.000134	CcSEcCtD
Zonisamide—Dry mouth—Epirubicin—prostate cancer	2.17e-05	0.000134	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—prostate cancer	2.16e-05	0.000133	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—prostate cancer	2.16e-05	0.000133	CcSEcCtD
Zonisamide—Urticaria—Prednisone—prostate cancer	2.16e-05	0.000133	CcSEcCtD
Zonisamide—Pruritus—Capecitabine—prostate cancer	2.16e-05	0.000133	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—prostate cancer	2.16e-05	0.000133	CcSEcCtD
Zonisamide—Diarrhoea—Docetaxel—prostate cancer	2.15e-05	0.000133	CcSEcCtD
Zonisamide—Abdominal pain—Prednisone—prostate cancer	2.15e-05	0.000132	CcSEcCtD
Zonisamide—Body temperature increased—Prednisone—prostate cancer	2.15e-05	0.000132	CcSEcCtD
Zonisamide—Confusional state—Epirubicin—prostate cancer	2.14e-05	0.000132	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—prostate cancer	2.13e-05	0.000131	CcSEcCtD
Zonisamide—Oedema—Epirubicin—prostate cancer	2.12e-05	0.000131	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—prostate cancer	2.12e-05	0.00013	CcSEcCtD
Zonisamide—Infection—Epirubicin—prostate cancer	2.11e-05	0.00013	CcSEcCtD
Zonisamide—Cough—Doxorubicin—prostate cancer	2.1e-05	0.000129	CcSEcCtD
Zonisamide—Shock—Epirubicin—prostate cancer	2.09e-05	0.000129	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—prostate cancer	2.09e-05	0.000129	CcSEcCtD
Zonisamide—Diarrhoea—Capecitabine—prostate cancer	2.09e-05	0.000129	CcSEcCtD
Zonisamide—Nervous system disorder—Epirubicin—prostate cancer	2.08e-05	0.000128	CcSEcCtD
Zonisamide—Dizziness—Docetaxel—prostate cancer	2.08e-05	0.000128	CcSEcCtD
Zonisamide—Thrombocytopenia—Epirubicin—prostate cancer	2.08e-05	0.000128	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—prostate cancer	2.08e-05	0.000128	CcSEcCtD
Zonisamide—Tachycardia—Epirubicin—prostate cancer	2.07e-05	0.000128	CcSEcCtD
Zonisamide—Skin disorder—Epirubicin—prostate cancer	2.06e-05	0.000127	CcSEcCtD
Zonisamide—Hyperhidrosis—Epirubicin—prostate cancer	2.05e-05	0.000127	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—prostate cancer	2.05e-05	0.000126	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—prostate cancer	2.05e-05	0.000126	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—prostate cancer	2.05e-05	0.000126	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—prostate cancer	2.04e-05	0.000126	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.04e-05	0.000125	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—prostate cancer	2.03e-05	0.000125	CcSEcCtD
Zonisamide—Anorexia—Epirubicin—prostate cancer	2.02e-05	0.000125	CcSEcCtD
Zonisamide—Dizziness—Capecitabine—prostate cancer	2.02e-05	0.000124	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—prostate cancer	2.01e-05	0.000124	CcSEcCtD
Zonisamide—Vomiting—Docetaxel—prostate cancer	2e-05	0.000123	CcSEcCtD
Zonisamide—Hypersensitivity—Prednisone—prostate cancer	2e-05	0.000123	CcSEcCtD
Zonisamide—Rash—Docetaxel—prostate cancer	1.99e-05	0.000122	CcSEcCtD
Zonisamide—Hypotension—Epirubicin—prostate cancer	1.99e-05	0.000122	CcSEcCtD
Zonisamide—Dermatitis—Docetaxel—prostate cancer	1.98e-05	0.000122	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—prostate cancer	1.98e-05	0.000122	CcSEcCtD
Zonisamide—Headache—Docetaxel—prostate cancer	1.97e-05	0.000122	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—prostate cancer	1.97e-05	0.000121	CcSEcCtD
Zonisamide—Infection—Doxorubicin—prostate cancer	1.95e-05	0.00012	CcSEcCtD
Zonisamide—Asthenia—Prednisone—prostate cancer	1.95e-05	0.00012	CcSEcCtD
Zonisamide—Vomiting—Capecitabine—prostate cancer	1.94e-05	0.000119	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.94e-05	0.000119	CcSEcCtD
Zonisamide—Shock—Doxorubicin—prostate cancer	1.93e-05	0.000119	CcSEcCtD
Zonisamide—Nervous system disorder—Doxorubicin—prostate cancer	1.93e-05	0.000119	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—prostate cancer	1.92e-05	0.000119	CcSEcCtD
Zonisamide—Rash—Capecitabine—prostate cancer	1.92e-05	0.000118	CcSEcCtD
Zonisamide—Pruritus—Prednisone—prostate cancer	1.92e-05	0.000118	CcSEcCtD
Zonisamide—Insomnia—Epirubicin—prostate cancer	1.92e-05	0.000118	CcSEcCtD
Zonisamide—Dermatitis—Capecitabine—prostate cancer	1.92e-05	0.000118	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—prostate cancer	1.92e-05	0.000118	CcSEcCtD
Zonisamide—Headache—Capecitabine—prostate cancer	1.91e-05	0.000118	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—prostate cancer	1.91e-05	0.000118	CcSEcCtD
Zonisamide—Paraesthesia—Epirubicin—prostate cancer	1.91e-05	0.000118	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—prostate cancer	1.9e-05	0.000117	CcSEcCtD
Zonisamide—Dyspnoea—Epirubicin—prostate cancer	1.89e-05	0.000117	CcSEcCtD
Zonisamide—Somnolence—Epirubicin—prostate cancer	1.89e-05	0.000116	CcSEcCtD
Zonisamide—Anorexia—Doxorubicin—prostate cancer	1.87e-05	0.000115	CcSEcCtD
Zonisamide—Nausea—Docetaxel—prostate cancer	1.87e-05	0.000115	CcSEcCtD
Zonisamide—Dyspepsia—Epirubicin—prostate cancer	1.87e-05	0.000115	CcSEcCtD
Zonisamide—Diarrhoea—Prednisone—prostate cancer	1.86e-05	0.000115	CcSEcCtD
Zonisamide—Decreased appetite—Epirubicin—prostate cancer	1.85e-05	0.000114	CcSEcCtD
Zonisamide—Hypotension—Doxorubicin—prostate cancer	1.84e-05	0.000113	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Epirubicin—prostate cancer	1.83e-05	0.000113	CcSEcCtD
Zonisamide—Fatigue—Epirubicin—prostate cancer	1.83e-05	0.000113	CcSEcCtD
Zonisamide—Constipation—Epirubicin—prostate cancer	1.82e-05	0.000112	CcSEcCtD
Zonisamide—Nausea—Capecitabine—prostate cancer	1.81e-05	0.000112	CcSEcCtD
Zonisamide—Dizziness—Prednisone—prostate cancer	1.8e-05	0.000111	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.79e-05	0.00011	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—prostate cancer	1.78e-05	0.00011	CcSEcCtD
Zonisamide—Paraesthesia—Doxorubicin—prostate cancer	1.77e-05	0.000109	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—prostate cancer	1.75e-05	0.000108	CcSEcCtD
Zonisamide—Feeling abnormal—Epirubicin—prostate cancer	1.75e-05	0.000108	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—prostate cancer	1.75e-05	0.000108	CcSEcCtD
Zonisamide—Gastrointestinal pain—Epirubicin—prostate cancer	1.74e-05	0.000107	CcSEcCtD
Zonisamide—Dyspepsia—Doxorubicin—prostate cancer	1.73e-05	0.000107	CcSEcCtD
Zonisamide—Vomiting—Prednisone—prostate cancer	1.73e-05	0.000106	CcSEcCtD
Zonisamide—Rash—Prednisone—prostate cancer	1.71e-05	0.000106	CcSEcCtD
Zonisamide—Dermatitis—Prednisone—prostate cancer	1.71e-05	0.000105	CcSEcCtD
Zonisamide—Decreased appetite—Doxorubicin—prostate cancer	1.71e-05	0.000105	CcSEcCtD
Zonisamide—Headache—Prednisone—prostate cancer	1.7e-05	0.000105	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.7e-05	0.000105	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—prostate cancer	1.69e-05	0.000104	CcSEcCtD
Zonisamide—Urticaria—Epirubicin—prostate cancer	1.69e-05	0.000104	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—prostate cancer	1.68e-05	0.000104	CcSEcCtD
Zonisamide—Body temperature increased—Epirubicin—prostate cancer	1.68e-05	0.000103	CcSEcCtD
Zonisamide—Abdominal pain—Epirubicin—prostate cancer	1.68e-05	0.000103	CcSEcCtD
Zonisamide—Feeling abnormal—Doxorubicin—prostate cancer	1.62e-05	9.98e-05	CcSEcCtD
Zonisamide—Nausea—Prednisone—prostate cancer	1.61e-05	9.94e-05	CcSEcCtD
Zonisamide—Gastrointestinal pain—Doxorubicin—prostate cancer	1.61e-05	9.9e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Epirubicin—prostate cancer	1.57e-05	9.64e-05	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—prostate cancer	1.56e-05	9.62e-05	CcSEcCtD
Zonisamide—Body temperature increased—Doxorubicin—prostate cancer	1.55e-05	9.57e-05	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—prostate cancer	1.55e-05	9.57e-05	CcSEcCtD
Zonisamide—Asthenia—Epirubicin—prostate cancer	1.52e-05	9.39e-05	CcSEcCtD
Zonisamide—Pruritus—Epirubicin—prostate cancer	1.5e-05	9.26e-05	CcSEcCtD
Zonisamide—Diarrhoea—Epirubicin—prostate cancer	1.45e-05	8.96e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Doxorubicin—prostate cancer	1.45e-05	8.92e-05	CcSEcCtD
Zonisamide—Asthenia—Doxorubicin—prostate cancer	1.41e-05	8.69e-05	CcSEcCtD
Zonisamide—Dizziness—Epirubicin—prostate cancer	1.4e-05	8.66e-05	CcSEcCtD
Zonisamide—Pruritus—Doxorubicin—prostate cancer	1.39e-05	8.57e-05	CcSEcCtD
Zonisamide—Vomiting—Epirubicin—prostate cancer	1.35e-05	8.32e-05	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—prostate cancer	1.34e-05	8.29e-05	CcSEcCtD
Zonisamide—Rash—Epirubicin—prostate cancer	1.34e-05	8.25e-05	CcSEcCtD
Zonisamide—Dermatitis—Epirubicin—prostate cancer	1.34e-05	8.25e-05	CcSEcCtD
Zonisamide—Headache—Epirubicin—prostate cancer	1.33e-05	8.2e-05	CcSEcCtD
Zonisamide—Dizziness—Doxorubicin—prostate cancer	1.3e-05	8.01e-05	CcSEcCtD
Zonisamide—Nausea—Epirubicin—prostate cancer	1.26e-05	7.77e-05	CcSEcCtD
Zonisamide—Vomiting—Doxorubicin—prostate cancer	1.25e-05	7.7e-05	CcSEcCtD
Zonisamide—Rash—Doxorubicin—prostate cancer	1.24e-05	7.64e-05	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—prostate cancer	1.24e-05	7.63e-05	CcSEcCtD
Zonisamide—Headache—Doxorubicin—prostate cancer	1.23e-05	7.59e-05	CcSEcCtD
Zonisamide—Nausea—Doxorubicin—prostate cancer	1.17e-05	7.19e-05	CcSEcCtD
Zonisamide—CYP2C19—Metabolism—GSTA3—prostate cancer	2.77e-06	2.43e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—INS—prostate cancer	2.75e-06	2.41e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN1A—prostate cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTM3—prostate cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AOX1—prostate cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MBTPS1—prostate cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NAGLU—prostate cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—RFK—prostate cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SULT2B1—prostate cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PGAM2—prostate cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTEN—prostate cancer	2.72e-06	2.39e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CD—prostate cancer	2.71e-06	2.38e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CREBBP—prostate cancer	2.7e-06	2.36e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CB—prostate cancer	2.69e-06	2.36e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—COMT—prostate cancer	2.69e-06	2.36e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTP1—prostate cancer	2.67e-06	2.35e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—prostate cancer	2.66e-06	2.34e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CA—prostate cancer	2.65e-06	2.33e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—prostate cancer	2.65e-06	2.33e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSD3B1—prostate cancer	2.64e-06	2.32e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC22A3—prostate cancer	2.64e-06	2.32e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CB—prostate cancer	2.64e-06	2.31e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ITPR1—prostate cancer	2.63e-06	2.31e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—prostate cancer	2.61e-06	2.29e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EP300—prostate cancer	2.59e-06	2.28e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CA—prostate cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CA—prostate cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP3A43—prostate cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AMACR—prostate cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—DEGS1—prostate cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NAT1—prostate cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SRD5A2—prostate cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.56e-06	2.25e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NOS3—prostate cancer	2.56e-06	2.25e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CD—prostate cancer	2.56e-06	2.24e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TBXAS1—prostate cancer	2.53e-06	2.22e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTA4—prostate cancer	2.53e-06	2.22e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTEN—prostate cancer	2.53e-06	2.22e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—SRC—prostate cancer	2.52e-06	2.21e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TYMS—prostate cancer	2.49e-06	2.18e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.48e-06	2.17e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTA2—prostate cancer	2.47e-06	2.17e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD17B1—prostate cancer	2.46e-06	2.16e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTM1—prostate cancer	2.46e-06	2.16e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT1—prostate cancer	2.45e-06	2.15e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCG5—prostate cancer	2.44e-06	2.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SULT1A1—prostate cancer	2.44e-06	2.14e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—STAT3—prostate cancer	2.43e-06	2.13e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTEN—prostate cancer	2.42e-06	2.13e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CA—prostate cancer	2.41e-06	2.12e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CA—prostate cancer	2.41e-06	2.12e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NOS3—prostate cancer	2.41e-06	2.12e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—LPL—prostate cancer	2.41e-06	2.12e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—EP300—prostate cancer	2.41e-06	2.11e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTA1—prostate cancer	2.38e-06	2.09e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CB—prostate cancer	2.36e-06	2.07e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSD3B2—prostate cancer	2.35e-06	2.07e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NAT2—prostate cancer	2.35e-06	2.07e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTO1—prostate cancer	2.35e-06	2.07e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—prostate cancer	2.34e-06	2.05e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1A1—prostate cancer	2.33e-06	2.04e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTEN—prostate cancer	2.32e-06	2.04e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—EP300—prostate cancer	2.31e-06	2.03e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ERCC2—prostate cancer	2.31e-06	2.03e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTEN—prostate cancer	2.28e-06	2e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.26e-06	1.99e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—prostate cancer	2.26e-06	1.98e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—LRP2—prostate cancer	2.26e-06	1.98e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PLCB2—prostate cancer	2.26e-06	1.98e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2C18—prostate cancer	2.26e-06	1.98e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—TGFB1—prostate cancer	2.25e-06	1.98e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CA—prostate cancer	2.24e-06	1.96e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CB—prostate cancer	2.23e-06	1.95e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—EP300—prostate cancer	2.22e-06	1.94e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—P4HB—prostate cancer	2.21e-06	1.94e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—prostate cancer	2.21e-06	1.94e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—prostate cancer	2.21e-06	1.94e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—B4GALT4—prostate cancer	2.2e-06	1.93e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HPGD—prostate cancer	2.2e-06	1.93e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—EP300—prostate cancer	2.17e-06	1.91e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MTHFR—prostate cancer	2.17e-06	1.9e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AKT1—prostate cancer	2.17e-06	1.9e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC22A1—prostate cancer	2.15e-06	1.89e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPARA—prostate cancer	2.13e-06	1.87e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.13e-06	1.87e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AKT1—prostate cancer	2.11e-06	1.85e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AKT1—prostate cancer	2.11e-06	1.85e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SULT2A1—prostate cancer	2.1e-06	1.84e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—prostate cancer	2.09e-06	1.83e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	2.07e-06	1.81e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MED12—prostate cancer	2.06e-06	1.81e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GNG5—prostate cancer	2.05e-06	1.8e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTEN—prostate cancer	2.04e-06	1.79e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP7B1—prostate cancer	2.01e-06	1.76e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTAP—prostate cancer	2.01e-06	1.76e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CAV1—prostate cancer	2e-06	1.76e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOA3—prostate cancer	1.97e-06	1.73e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AKT1—prostate cancer	1.97e-06	1.73e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AKT1—prostate cancer	1.97e-06	1.73e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.96e-06	1.72e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.96e-06	1.72e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—EP300—prostate cancer	1.95e-06	1.71e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.94e-06	1.7e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTEN—prostate cancer	1.92e-06	1.69e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CA—prostate cancer	1.92e-06	1.68e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HPGDS—prostate cancer	1.88e-06	1.65e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ACSL4—prostate cancer	1.87e-06	1.64e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.87e-06	1.64e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—EP300—prostate cancer	1.84e-06	1.61e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AKT1—prostate cancer	1.83e-06	1.6e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTT1—prostate cancer	1.83e-06	1.6e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ACHE—prostate cancer	1.83e-06	1.6e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CG—prostate cancer	1.82e-06	1.6e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2A6—prostate cancer	1.8e-06	1.58e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.8e-06	1.58e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ARG2—prostate cancer	1.79e-06	1.57e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PHGDH—prostate cancer	1.79e-06	1.57e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—UMPS—prostate cancer	1.79e-06	1.57e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CA—prostate cancer	1.78e-06	1.56e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LDHB—prostate cancer	1.76e-06	1.54e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKR1C3—prostate cancer	1.76e-06	1.54e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PRKACB—prostate cancer	1.75e-06	1.53e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP17A1—prostate cancer	1.73e-06	1.52e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—INS—prostate cancer	1.73e-06	1.51e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.72e-06	1.51e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CA—prostate cancer	1.71e-06	1.5e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.7e-06	1.5e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—prostate cancer	1.7e-06	1.49e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CREBBP—prostate cancer	1.69e-06	1.48e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PDHA1—prostate cancer	1.66e-06	1.46e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—UCP3—prostate cancer	1.66e-06	1.46e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TCN2—prostate cancer	1.66e-06	1.46e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTA3—prostate cancer	1.66e-06	1.46e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOA2—prostate cancer	1.65e-06	1.44e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CA—prostate cancer	1.64e-06	1.44e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CA—prostate cancer	1.61e-06	1.41e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CD—prostate cancer	1.6e-06	1.41e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.59e-06	1.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.59e-06	1.39e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC5A5—prostate cancer	1.57e-06	1.38e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT1—prostate cancer	1.57e-06	1.38e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2E1—prostate cancer	1.53e-06	1.35e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.52e-06	1.34e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTA4—prostate cancer	1.52e-06	1.34e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NQO1—prostate cancer	1.52e-06	1.33e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NOS3—prostate cancer	1.51e-06	1.33e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TH—prostate cancer	1.5e-06	1.31e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTA2—prostate cancer	1.48e-06	1.3e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP3A4—prostate cancer	1.48e-06	1.3e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.47e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.47e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCG5—prostate cancer	1.47e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AKT1—prostate cancer	1.46e-06	1.28e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1B1—prostate cancer	1.45e-06	1.28e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CA—prostate cancer	1.44e-06	1.26e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTA1—prostate cancer	1.43e-06	1.26e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NAT2—prostate cancer	1.42e-06	1.24e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTO1—prostate cancer	1.42e-06	1.24e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.42e-06	1.24e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GGT1—prostate cancer	1.41e-06	1.24e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CB—prostate cancer	1.4e-06	1.23e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AKT1—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOA1—prostate cancer	1.39e-06	1.22e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—prostate cancer	1.38e-06	1.21e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.37e-06	1.2e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CA—prostate cancer	1.36e-06	1.19e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PLCB2—prostate cancer	1.36e-06	1.19e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.36e-06	1.19e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LRP2—prostate cancer	1.36e-06	1.19e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKT1—prostate cancer	1.34e-06	1.17e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—P4HB—prostate cancer	1.33e-06	1.17e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—RXRA—prostate cancer	1.32e-06	1.16e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKT1—prostate cancer	1.31e-06	1.15e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.29e-06	1.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.28e-06	1.13e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—COMT—prostate cancer	1.27e-06	1.12e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTP1—prostate cancer	1.27e-06	1.11e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.26e-06	1.11e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ITPR1—prostate cancer	1.25e-06	1.09e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MED12—prostate cancer	1.24e-06	1.09e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GNG5—prostate cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTEN—prostate cancer	1.21e-06	1.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOA3—prostate cancer	1.19e-06	1.04e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKT1—prostate cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TYMS—prostate cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTM1—prostate cancer	1.16e-06	1.02e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—EP300—prostate cancer	1.15e-06	1.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—LPL—prostate cancer	1.14e-06	1e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HPGDS—prostate cancer	1.13e-06	9.93e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.12e-06	9.87e-06	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKT1—prostate cancer	1.11e-06	9.73e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.1e-06	9.67e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTT1—prostate cancer	1.1e-06	9.63e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ACHE—prostate cancer	1.1e-06	9.63e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ERCC2—prostate cancer	1.09e-06	9.59e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.09e-06	9.52e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.06e-06	9.26e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PRKACB—prostate cancer	1.05e-06	9.21e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.04e-06	9.12e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTHFR—prostate cancer	1.03e-06	9.02e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPARA—prostate cancer	1.01e-06	8.84e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOA2—prostate cancer	9.9e-07	8.69e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CAV1—prostate cancer	9.48e-07	8.32e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC5A5—prostate cancer	9.45e-07	8.29e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2E1—prostate cancer	9.23e-07	8.09e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NQO1—prostate cancer	9.12e-07	8e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.06e-07	7.94e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TH—prostate cancer	8.99e-07	7.89e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1B1—prostate cancer	8.75e-07	7.67e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CG—prostate cancer	8.63e-07	7.57e-06	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CA—prostate cancer	8.52e-07	7.47e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GGT1—prostate cancer	8.47e-07	7.43e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOA1—prostate cancer	8.34e-07	7.32e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP19A1—prostate cancer	8.22e-07	7.21e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—INS—prostate cancer	8.17e-07	7.17e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CREBBP—prostate cancer	8e-07	7.02e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—RXRA—prostate cancer	7.94e-07	6.96e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—COMT—prostate cancer	7.64e-07	6.71e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTP1—prostate cancer	7.61e-07	6.68e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CD—prostate cancer	7.59e-07	6.66e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ITPR1—prostate cancer	7.49e-07	6.57e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NOS3—prostate cancer	7.17e-07	6.29e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TYMS—prostate cancer	7.07e-07	6.21e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTM1—prostate cancer	6.99e-07	6.13e-06	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKT1—prostate cancer	6.96e-07	6.11e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LPL—prostate cancer	6.86e-07	6.02e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.63e-07	5.82e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.62e-07	5.8e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ERCC2—prostate cancer	6.57e-07	5.77e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—prostate cancer	6.56e-07	5.75e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTHFR—prostate cancer	6.18e-07	5.42e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPARA—prostate cancer	6.06e-07	5.32e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTEN—prostate cancer	5.72e-07	5.02e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CAV1—prostate cancer	5.7e-07	5e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—EP300—prostate cancer	5.45e-07	4.78e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CG—prostate cancer	5.19e-07	4.55e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—INS—prostate cancer	4.91e-07	4.31e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CREBBP—prostate cancer	4.81e-07	4.22e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.56e-07	4e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NOS3—prostate cancer	4.31e-07	3.78e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CA—prostate cancer	4.03e-07	3.54e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.98e-07	3.49e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—prostate cancer	3.94e-07	3.46e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTEN—prostate cancer	3.44e-07	3.02e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKT1—prostate cancer	3.29e-07	2.89e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—EP300—prostate cancer	3.28e-07	2.88e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.43e-07	2.13e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKT1—prostate cancer	1.98e-07	1.74e-06	CbGpPWpGaD
